You are here: Home » News-IANS » Lifestyle-Fashion
Business Standard

Diabetes may have a new cure in Platypus venom

IANS  |  Sydney 

A hormone produced in the venom of platypus -- an egg-laying mammal native to -- can pave the way for potential new treatments for Type 2 diabetes in humans, researchers have found.

The study found that platypus produces hormone glucagon-like peptide-1 (GLP-1) -- normally secreted in the gut of both humans and animals for stimulating the release of insulin to lower blood glucose, but insufficient to maintain proper blood sugar balance.

"Our research has discovered that platypus have evolved changes in the hormone GLP-1 that make it resistant to the rapid degradation normally seen in humans," said Professor Frank Grutzner of the University of Adelaide in Australia.

The GLP-1 hormone produced in the gut of the platypus, which helps regulate blood glucose, is also produced in their venom to fend off other platypus males during breeding season, the researchers said.

"This tug of war between the different functions has resulted in dramatic changes in the GLP-1 system. The function in venom has most likely triggered the evolution of a stable form of GLP-1 in monotremes.

"Stable GLP-1 molecules are highly desirable as potential Type 2 diabetes treatments," added Briony Forbes, Associate Professor at Flinders University.

In addition, GLP-1 has also been discovered in the venom of echidnas -- another egg-laying mammal.

While the platypus has spurs on its hind limbs for delivering a large amount of venom to its opponent, there is no such spur on echidnas.

"The lack of spur on echidnas remains an evolutionary mystery, but the fact that both platypus and echidnas have evolved the same long-lasting form of the hormone GLP-1 is in itself very exciting," Grutzner said.

These findings have the potential to improve diabetes treatment, one of our greatest health challenges, "although exactly how we can convert this finding into a treatment will need to be the subject of future research," Grutzner observed, in the paper published in the journal Scientific Reports.

--IANS

rt/in/dg

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU

Diabetes may have a new cure in Platypus venom

A hormone produced in the venom of platypus -- an egg-laying mammal native to Australia -- can pave the way for potential new treatments for Type 2 diabetes in humans, researchers have found.

A hormone produced in the venom of platypus -- an egg-laying mammal native to -- can pave the way for potential new treatments for Type 2 diabetes in humans, researchers have found.

The study found that platypus produces hormone glucagon-like peptide-1 (GLP-1) -- normally secreted in the gut of both humans and animals for stimulating the release of insulin to lower blood glucose, but insufficient to maintain proper blood sugar balance.

"Our research has discovered that platypus have evolved changes in the hormone GLP-1 that make it resistant to the rapid degradation normally seen in humans," said Professor Frank Grutzner of the University of Adelaide in Australia.

The GLP-1 hormone produced in the gut of the platypus, which helps regulate blood glucose, is also produced in their venom to fend off other platypus males during breeding season, the researchers said.

"This tug of war between the different functions has resulted in dramatic changes in the GLP-1 system. The function in venom has most likely triggered the evolution of a stable form of GLP-1 in monotremes.

"Stable GLP-1 molecules are highly desirable as potential Type 2 diabetes treatments," added Briony Forbes, Associate Professor at Flinders University.

In addition, GLP-1 has also been discovered in the venom of echidnas -- another egg-laying mammal.

While the platypus has spurs on its hind limbs for delivering a large amount of venom to its opponent, there is no such spur on echidnas.

"The lack of spur on echidnas remains an evolutionary mystery, but the fact that both platypus and echidnas have evolved the same long-lasting form of the hormone GLP-1 is in itself very exciting," Grutzner said.

These findings have the potential to improve diabetes treatment, one of our greatest health challenges, "although exactly how we can convert this finding into a treatment will need to be the subject of future research," Grutzner observed, in the paper published in the journal Scientific Reports.

--IANS

rt/in/dg

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Diabetes may have a new cure in Platypus venom

A hormone produced in the venom of platypus -- an egg-laying mammal native to -- can pave the way for potential new treatments for Type 2 diabetes in humans, researchers have found.

The study found that platypus produces hormone glucagon-like peptide-1 (GLP-1) -- normally secreted in the gut of both humans and animals for stimulating the release of insulin to lower blood glucose, but insufficient to maintain proper blood sugar balance.

"Our research has discovered that platypus have evolved changes in the hormone GLP-1 that make it resistant to the rapid degradation normally seen in humans," said Professor Frank Grutzner of the University of Adelaide in Australia.

The GLP-1 hormone produced in the gut of the platypus, which helps regulate blood glucose, is also produced in their venom to fend off other platypus males during breeding season, the researchers said.

"This tug of war between the different functions has resulted in dramatic changes in the GLP-1 system. The function in venom has most likely triggered the evolution of a stable form of GLP-1 in monotremes.

"Stable GLP-1 molecules are highly desirable as potential Type 2 diabetes treatments," added Briony Forbes, Associate Professor at Flinders University.

In addition, GLP-1 has also been discovered in the venom of echidnas -- another egg-laying mammal.

While the platypus has spurs on its hind limbs for delivering a large amount of venom to its opponent, there is no such spur on echidnas.

"The lack of spur on echidnas remains an evolutionary mystery, but the fact that both platypus and echidnas have evolved the same long-lasting form of the hormone GLP-1 is in itself very exciting," Grutzner said.

These findings have the potential to improve diabetes treatment, one of our greatest health challenges, "although exactly how we can convert this finding into a treatment will need to be the subject of future research," Grutzner observed, in the paper published in the journal Scientific Reports.

--IANS

rt/in/dg

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard